UTILITY THERAPEUTICS

utility-therapeutics-logo

UTILITY therapeutics is focused on developing and commercialising antibiotics in the US, to address the significant threat faced by healthcare systems and patients from multi-drug resistant bacterial infections. The World Health Organisation has stated that antibiotic resistance is one of the biggest threats to global health, food security, and development today.

#SimilarOrganizations #People #Website #More

UTILITY THERAPEUTICS

Social Links:

Industry:
Biotechnology Life Science

Founded:
2017-01-01

Address:
Altrincham, Cheshire, United Kingdom

Country:
United Kingdom

Website Url:
http://www.utilitytherapeutics.com

Total Employee:
1+

Status:
Active

Contact:
+44 203 930 9665

Email Addresses:
[email protected]


Similar Organizations

gyala-therapeutics-logo

Gyala Therapeutics

Gyala Therapeutics is focused on developing new CAR-T therapies for treating hematological malignancies.

reflection-therapeutics-logo

Reflection Therapeutics

Reflection Therapeutics is developing cell therapy technology against neuroinflammation across the board.

Current Employees Featured

morten-o-a-sommer_image

Morten O. A. Sommer
Morten O. A. Sommer Co-Founder and Board Member @ UTILITY therapeutics
Co-Founder and Board Member
2018-01-01

thomas-hadley_image

Thomas Hadley
Thomas Hadley President & Chief Commercial Officer @ UTILITY therapeutics
President & Chief Commercial Officer
2020-07-01

Founder


morten-o-a-sommer_image

Morten O. A. Sommer

Official Site Inspections

http://www.utilitytherapeutics.com Semrush global rank: 9.58 M Semrush visits lastest month: 351

  • Host name: srv870947.hstgr.cloud
  • IP address: 147.93.104.183
  • Location: Belgium
  • Latitude: 50.8509
  • Longitude: 4.3447
  • Timezone: Europe/Brussels

Loading ...

More informations about "UTILITY therapeutics"

About Us – Utility Therapeutics

Alan S. Roemer, MBA, MPH is an entrepreneurial life sciences executive and board member who has launched three multi-billion dollar biotechnology companies, raised over $1.75 billion in …See details»

UTILITY Therapeutics - Developing Antibiotics to Treat Drug …

The growing threat of antimicrobial resistance, treatment overuse, and challenges with existing therapies further increase the economic and societal burden of these infections. 1 UTILITY …See details»

UTILITY therapeutics - LinkedIn

UTILITY therapeutics | 786 followers on LinkedIn. First Line in the fight against anti-microbial resistance | UTILITY therapeutics Ltd., a biotechnology company focused on the U.S. …See details»

UTILITY therapeutics - Crunchbase Company Profile & Funding

Contact Email [email protected] Phone Number +44 203 930 9665 UTILITY therapeutics is focused on developing and commercialising antibiotics in the US, to address …See details»

Our Focus – Utility Therapeutics

Enterobacteriaceae is a gram-negative family of bacteria, including E coli, that are a common cause of numerous infections in humans. 11,12 In fact, most UTIs are caused by E coli. 12 …See details»

UTILITY THERAPEUTICS LTD - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for UTILITY THERAPEUTICS LTD of ALTRINCHAM. Get the latest business insights from Dun & Bradstreet.See details»

UTILITY therapeutics - 2025 Company Profile - Tracxn

Mar 7, 2025 UTILITY therapeutics - Developer of antibiotics to treat urinary tract infections and multi-drug resistant infections. Raised a total funding of $2.52M over 2 rounds from 10 …See details»

UTILITY therapeutics - VentureRadar

Website: https://utilitytherapeutics.com/ Develops and launches effective antibiotic treatments for resistant infections, focusing on urinary tract infections, with a ...See details»

UTILITY Therapeutics - PitchBook

UTILITY Therapeutics General Information Description. Developer of antibiotics and therapies intended to treat multi-drug resistant bacterial infections. The company develops mecillinam …See details»

UTILITY Therapeutics - Craft

UTILITY Therapeutics is a company focused on developing and commercializing antibiotics against multi-drug resistant bacterial infections. It offers mecillinam, and its oral pro-drug …See details»

UTILITY Therapeutics Announces Scientific Advisory Board

SAB includes key opinion leaders for infectious diseases and urinary tract infections LONDON, UK / ACCESSWIRE / May 11, 2021 /Â UTILITY therapeutics Ltd., a biotechnology company …See details»

Investor Relations News & Publications – Utility Therapeutics

You are about to leave the UTILITYtherapeutics.com website by opening a new webpage. The site you are linking to is not controlled or endorsed by UTILITY therapeutics and we are not …See details»

UTILITY therapeutics Company Profile: Overview and Full News …

Utilitytherapeutics.com. Overview: UTILITY therapeutics. UTILITY therapeutics is a commercial company based in Cheshire that is focused on developing innovative antibiotics to treat drug …See details»

UTILITY therapeutics - Overview, News & Similar companies

Sep 24, 2018 UTILITY therapeutics contact info: Phone number: +44 2016040225 Website: www.utilitytherapeutics.com What does UTILITY therapeutics do? UTILITY therapeutics is …See details»

UTILITY therapeutics Ltd. Announces Financing Led by the AMR

Jan 17, 2024 For additional information, please visit www.utilitytherapeutics.com. Contact. Tom Hadley Chief Executive Officer Tel: +1 (973) 224-7272 [email protected]. …See details»

UTILITY Receives Investigational New Drug Approval from US FDA

Sep 19, 2018 UTILITY therapeutics Mark Beards, +44 203 930 9665 CEO [email protected] or Consilium Strategic Communications Mary-Jane Elliott, Chris …See details»

Contact – Utility Therapeutics

For more information about UTILITY therapeutics, products, or collaboration opportunities, contact UTILITY therapeutics at [email protected]See details»

Utility Therapeutics Ltd. | Insights

Jan 31, 2025 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»

UTILITY Therapeutics Preparing NDA Submission – 3BFuture

Jun 15, 2021 Pivmecillinam NDA submission targeted for fourth quarter of 2021 LONDON, ENGLAND / ACCESSWIRE / June 15, 2021 /Â UTILITY therapeutics Ltd., a biotechnology …See details»

UTILITY therapeutics Ltd. (UTILITY therapeutics Ltd.) - 药物管线_专 …

Utilitytherapeutics.com. 更新于:2025-03-08. ... 2017, and 97 more, including 40 non-traditional options, are moving through the pipeline, according to the World Health Organization. But as …See details»

linkstock.net © 2022. All rights reserved